IMMUNITYBIO, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-38.6M | $-45.2M | $6.6M | $73.9M |
| FY2017 | $-48.8M | $-83.6M | $34.8M | $37.0M |
| FY2018 | $-63.4M | $-76.5M | $13.1M | $23.4M |
| FY2019 | $-152.1M | $-156.4M | $4.3M | $3.4M |
| FY2020 | $-171.7M | $-173.4M | $1.7M | $2.2M |
| FY2021 | $-274.4M | $-308.0M | $33.6M | $57.2M |
| FY2022 | $-337.5M | $-415.7M | $78.2M | $40.2M |
| FY2023 | $-366.8M | $-397.3M | $30.6M | $49.2M |
| FY2024 | $-391.2M | $-398.1M | $6.9M | $34.4M |
| FY2025 | $-304.9M | $-308.8M | $3.8M | $36.8M |